Hubei wei shi reagent group ltd., company
Firmenname:
Hubei wei shi reagent group ltd., company
Telefon:
027-027-59101766
E-Mail:
2853877621@qq.com
Nationalität:
China
URL:
https://www.4008081911.com
Produkte insgesamt:
3716
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
Produktkatalog
Carbon tetrabromide
Kohlenstofftetrabromid
558-13-4
CBr4
Cyclosporin C
69787-61-0
C62H111N11O13
Mivacurium chloride
106861-44-3
C58H80ClN2O14+
2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone
32384-65-9
C18H42O6Si4
Dimetridazole
Dimetridazol
551-92-8
C5H7N3O2
Florfenicol
76639-94-6
C12H14Cl2FNO4S
Bendazac
Bendazac
20187-55-7
C16H14N2O3
2-Amino-1,3-propanediol
2-Aminopropan-1,3-diol
534-03-2
C3H9NO2
Policresulen
9011-02-3
(C15H16O8S2)n
betamethasone 21-acetate
9-Fluor-11β,17,21-trihydroxy-16β-methylpregna-1,4-dien-3,20-dion-21-acetat
987-24-6
C24H31FO6
Nitrofurantoin
1-(((5-Nitro-2-furanyl)methylen)-amino)-2,4-imidazolidindion
67-20-9
C8H6N4O5
pyrantel pamoate sigmaultra
4,4'-Methylenbis[3-hydroxy-2-naphthoe]sure, Verbindung mit (E)-1,4,5,6-Tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidin (1:1)
22204-24-6
C34H30N2O6S
Eplerenone
107724-20-9
C24H30O6
Oxiglutatione
Bi(glutathion-S-yl)
27025-41-8
C20H32N6O12S2
Cefuroxime
55268-75-2
C16H16N4O8S
L-Carnosine
Carnosin
305-84-0
C9H14N4O3
D-Epoxone
18422-53-2
C12H18O6
:3-Bromocyclohexene
1521-51-3
C6H9Br
1,2,3,5-TETRA-O-ACETYL-BETA-L-RIBOFURANOSE
144490-03-9
C13H18O9
Ustekinumab
815610-63-0
2,4-Dibromobenzyl Alcohol
666747-06-4
C7H6Br2O
N4-BENZOYL-2'-O-METHYLCYTIDINE
52571-45-6
C17H19N3O6
Trastuzumab
180288-69-1
C10H14N6O5
D-Galactosamine pentaacetate
76375-60-5
C16H23NO10
L-XYLOSE
L-(-)-Xylose
609-06-3
C5H10O5
L-FUCOSE
6-Desoxy-L-β-galaktose
2438-80-4
C6H12O5
PHENYL 1-THIO-BETA-D-GALACTOPYRANOSIDE
16758-34-2
C12H16O5S
7-OXIDE-7-AZAINDOLE
55052-24-9
C7H6N2O
Thailanstatin B
1426953-23-2
C28H42ClNO9
2,3-O-Isopropylidene-D-erythronolactone
25581-41-3
C7H10O4
5'-CHLORO-5'-DEOXYADENOSINE
892-48-8
C10H12ClN5O3
1-O-METHYL-BETA-D-GLUCURONIC ACID, SODIUM SALT
134253-42-2
C7H13NaO7
4-Chloro-3-(trifluoromethyl)phenyl isocyanate
327-78-6
C8H3ClF3NO
ReMogliflozin etabonate
442201-24-3
C26H38N2O9
2,3,5-TRI-O-BENZYL-D-RIBOFURANOSE
89615-45-2
C26H28O5
7-bromopyrrolo[1,2-f][1,2,4]triazin-4-amine
937046-98-5
C6H5BrN4
2,6-DICHLORO-5-FLUORONICOTINAMIDE
113237-20-0
C6H3Cl2FN2O
Methyl 4-Fluoro-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzoate
1235865-75-4
C15H11FN2O3
BPTA
89604-92-2
C20H22N4O4S3
Pembrolimumab
1374853-91-4
FMoc-NH-PEG2-CH2COOH
166108-71-0
C21H23NO6
Cetuximab
205923-56-4
C107H179N35O36S7
1,3-Dimethylpyrazole
694-48-4
C5H8N2
7-Benzyloxy-4-chloro-6-methoxy-quinoline
286371-49-1
C17H14ClNO2
IlludinS
1149-99-1
C15H20O4
Brivudine
69304-47-8
C11H13BrN2O5
:Fmoc-Lys(Mtt)-OH
167393-62-6
C41H40N2O4
Tetrahydro-4-pyranol
Tetrahydro-4H-pyran-4-ol
2081-44-9
C5H10O2
:Potassium D-erythronate
88759-55-1
C4H9KO5
Pamoic acid
3,3'-Dihydroxy-4,4'-methylendi-2-naphthoesure
130-85-8
C23H16O6
Bevacizumab
216974-75-3
C6638H10160N1720O2108S44
2,3,5-TRI-O-BENZYL-L-ARABINOFURANOSE
16838-89-4
C26H28O5
2,3,5-tri-O-benzyl-D-arabinofuranose
160549-10-0
C26H28O5
6-Chloro-3-methyluracil
4318-56-3
C5H5ClN2O2
5'-DMT-RIBO ADENOSINE (N-BZ)
81246-82-4
C38H35N5O7
Aminodiphenylmethane hydrochloride
Benzhydrylammoniumchlorid
5267-34-5
C13H14ClN
4-METHOXYPHENYL 2,3,4,6-TETRA-O-ACETYL-BETA-D-GLUCOPYANOSIDE
14581-81-8
C21H26O11
n-Dodecyl-N,N-Dimethylamine-N-Oxide
Dodecyldimethylaminoxid
1643-20-5
C14H31NO
2,3,4,6-Tetra-O-acetyl-alpha-D-galactopyranosyl bromide
Tetra-O-acetyl-α-D-galaktopyranosylbromid
3068-32-4
C14H19BrO9
Denosumab
615258-40-7
C6404H9912N1724O2004S50
Tocilizumab-Actemra
375823-41-9
C14H12O3
5-Bromopyrimidine
5-Brompyrimidin
4595-59-9
C4H3BrN2
FTIBAMZONE
210165-00-7
C14H15N7O2S2
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine
479633-63-1
C13H10ClN3O2S
N-BUTYLISOCYANIDE
2-Methylpropylisocyanid
7188-38-7
C5H9N
Omalizumab
242138-07-4
N-Methyl-4-chloropyridine-2-carboxamide
220000-87-3
C7H7ClN2O
2-ISOPROPYL-4-METHYLPYRIDIN-3-AMINE
1698293-93-4
C9H14N2
1-(4-FLUOROPHENYLCARBAMOYL)CYCLOPROPANECARBOXYLIC ACID
849217-48-7
C11H10FNO3
6-Bromoindanone
14548-39-1
C9H7BrO
Ferrous Bisglycinate
20150-34-9
C4H8FeN2O4
2-Pyridinol-1-oxide
2-Hydroxypyridin-1-oxid
13161-30-3
C5H5NO2
N-alpha-Fmoc-N-epsilon-4-methoxytrityl-L-lysine
159857-60-0
C41H40N2O5
N-Boc Cefcapene N,N-DiisopropylaMine
153012-37-4
C29H43N5O8S2
3-Methyl-3H-purin-6-aMine
1,10-Phenanthrolin
66-71-7
C12H8N2
4-Aminotetrahydropyran
38041-19-9
C5H11NO
Infliximab
170277-31-3
Rituximab
174722-31-7
C6416H9874N1688O1987S44
Ramucirumab
947687-13-0
Broxuridine
5-Brom-2'-deoxyuridin
59-14-3
C9H11BrN2O5
1-BENZHYDRYLAZETIDIN-3-ONE
40320-60-3
C16H15NO
Trimethyl orthobenzoate
Trimethylorthobenzoat
707-07-3
C10H14O3
N-Boc-pyrroline
73286-70-1
C9H15NO2
Pyrrolo[2,3-d]pyrimidin-4-ol
3680-71-5
C6H5N3O
Methyl 4-chloropicolinate
24484-93-3
C7H6ClNO2
4,6-O-Benzylidene-D-glucopyranose
97232-16-1
C13H16O6
Ethyl Tetrahydropyran-4-Carboxylate
96835-17-5
C8H14O3
2-Hydroxy-5-bromopyridine
13466-38-1
C5H4BrNO
2'-Deoxy-L-thymidine
3424-98-4
C10H14N2O5
Alirocumab
1245916-14-6
Atezolizumab
1380723-44-3
3-AMINO-2,2-DIMETHYL-PROPIONIC ACID ETHYL ESTER HYDROCHLORIDE
80253-38-9
C7H15NO2.ClH
1,2:5,6-Di-O-isopropylidene-alpha-D-allofuranose
2595-05-3
C12H20O6
4-Aminotetrahydropyran Hydrochloride
33024-60-1
C5H12ClNO
NXL 104
1192491-61-4
C7H12N3NaO6S
Eculizumab
219685-50-4
4-Chloro-alpha,alpha,alpha-trifluoro-m-toluidine
4-Chlor-α,α,α-trifluor-m-toluidin
320-51-4
C7H5ClF3N
(S)-(+)-3-Quinuclidinol
34583-34-1
C7H13NO
(R)-(-)-3-Quinuclidinol
(R)-Chinuclidin-3-ol
25333-42-0
C7H13NO
2-Hydrazinopyrazine
54608-52-5
C4H6N4
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
Copyright 2019 © ChemicalBook. All rights reserved